Sugar-induced modification of fibroblast growth factor 2 reduces its angiogenic activity in vivo (Q35747582)

10 August 2017

title

Sugar-induced modification of fibroblast growth factor 2 reduces its angiogenic activity in vivo (English)

1 reference

10 August 2017

Antonio Facchiano

0 references

Francesco Facchiano

1 reference

10 August 2017

Alessandro Lentini

1 reference

10 August 2017

Vincenzo Fogliano

1 reference

10 August 2017

Salvatore Mancarella

1 reference

10 August 2017

Cosmo Rossi

1 reference

10 August 2017

Maurizio C Capogrossi

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

The American Journal of Pathology

10 August 2017

published in

1 reference

10 August 2017

volume

161

1 reference

10 August 2017

1 reference

10 August 2017

page(s)

531-541

1 reference

Advanced glycation end-products: a review

10 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850725

Acidosis inhibits endothelial cell apoptosis and function and induces basic fibroblast growth factor and vascular endothelial growth factor expression.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850725

Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850725

Identification of a beta-lactoglobulin lactosylation site.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850725

AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850725

Immunological evidence for methylglyoxal-derived modifications in vivo. Determination of antigenic epitopes

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850725

Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850725

Methylation of high molecular weight fibroblast growth factor-2 determines post-translational increases in molecular weight and affects its intracellular distribution

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850725

Accumulation of Maillard reaction products in skin collagen in diabetes and aging

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850725

Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850725

Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosylation in diabetes

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850725

Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850725

Microvascular function in human diabetes. A physiological perspective

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850725

Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850725

Glucose and diabetic vascular disease.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850725

Role of oxygen in cross-linking and chemical modification of collagen by glucose

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850725

Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850725

A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850725

Heparin and heparan sulphate protect basic fibroblast growth factor from non-enzymic glycosylation

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850725

The advanced glycation end product Nepsilon-(carboxymethyl)lysine is increased in serum from children and adolescents with type 1 diabetes

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850725

Increased serum levels of advanced glycation end products (AGEs) in children and adolescents with IDDM.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850725

Effect of diabetes mellitus on formation of coronary collateral vessels

25 September 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964209-5

Role of glycation in modification of lens crystallins in diabetic and nondiabetic senile cataracts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964209-5

Effect of galactose on alpha-crystallin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964209-5

Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964209-5

Restriction fragment length polymorphism analysis of major histocompatibility complex genes in the non-obese diabetic mouse strain and its non-diabetic sister strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964209-5

Identification of N epsilon- carboxymethyllysine as a degradation product of fructoselysine in glycated protein.

7 January 2021

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/12163378

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Immunochemical detection of advanced glycosylation end products in vivo

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/12163378

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The chemotactic and mitogenic effects of platelet-derived growth factor-BB on rat aorta smooth muscle cells are inhibited by basic fibroblast growth factor

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/12163378

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/S0002-9440(10)64209-5

1 reference

10 August 2017

1 reference

10 August 2017

1 reference